Navigation Links
Guava Technologies Celebrates Tenth Anniversary
Date:2/6/2008

A decade of helping scientists and clinicians understand life one cell at a

time

HAYWARD, Calif., Feb. 6 /PRNewswire/ -- This year marks 10 years of Guava Technologies bringing sophisticated, yet uniquely easy-to-use, cellular analysis technologies directly to the lab benches of thousands of scientists and clinicians worldwide. Since 1998, the company has experienced continued success, achieving several significant milestones, including introduction of the first commercial microcapillary flow cytometer and introduction of a low-cost automated cell counting system for monitoring treatment of HIV/AIDS in remote parts of the world.

Guava Technologies develops microcapillary flow cytometers, which accommodate smaller sample volumes, generate less waste, have lower operating costs, and are easier to set up and maintain than the typical traditional flow cytometer. By leveraging the unique attributes of microcapillary based flow cytometry, the company's integrated systems enable scientists and clinicians not specialized in the technology to perform complex cellular analyses directly from their own lab bench -- quickly, simply, and cost-effectively. The company now has five systems and an ever-growing portfolio of reagents and assays on the market.

"We are exceptionally proud that virtually any scientist or clinician can learn to use a Guava System in less than one day," said Lawrence Bruder, Chief Executive Officer. "We have made steady progress toward our goal of making flow cytometry -- an absolutely critical technology for cell analysis -- directly accessible to almost any scientist or clinician who could benefit from it."

In addition, Guava Technologies has established a strong global sales and service organization with offices in Hayward, California, US, and Stamford, UK. "Truly believing that our customers come first, we have worked hard to ensure that we stand behind our products, and that our R&D
'/>"/>

SOURCE Guava Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
2. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
3. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
4. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
5. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
6. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
7. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
8. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
9. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
10. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
11. DNA Sequencing Equipment Market to Fragment and Grow as Competition, New Technologies Develop
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... ATLANTA , Aug. 28, 2014   SunTrust ... of three industry veterans to its equity research ... "Our ongoing expansion in equity research demonstrates ... with unique insights to enhance their investment decision ... Equities at STRH.  "We continue to make significant ...
(Date:8/28/2014)... Aug. 28, 2014  Armetheon, Inc. ( www.armetheon.com ... mid- to late-stage cardiovascular drug candidates, today announced ... first round of financing. The Series A round ... Bioventures with participation from investors that included Atheneos ... Dr. Larry Hsu , the founder of ...
(Date:8/28/2014)... 27, 2014 Scientists, researchers, and technologists ... SPIE Laser Damage 2014 symposium. Marking its 46th ... lasers will run 14-17 September. The event is sponsored ... photonics . , The premier conference for basic and ... to optical materials will engage researchers and engineers from ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 Earlier this ... University in partnership with the U.S. Air Force ... biofuel. The results indicated that this type of fuel ... feedstock and will be important to America’s Eco friendly ... now has a mandate to become independent of foreign ...
Breaking Biology Technology:SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 2SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 3Armetheon Completes $7.0 Million Series A Financing 2Armetheon Completes $7.0 Million Series A Financing 3Laser Damage to Draw Researchers, Engineers, Scientists to 46th Annual Conference 2Laser Damage to Draw Researchers, Engineers, Scientists to 46th Annual Conference 3Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 2Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 3Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 4Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 5
... - Non-responder and Null Responder HCV patients -- ... -BRISBANE, Calif., April 21 InterMune, Inc. (Nasdaq: ... innovative clinical study of protease inhibitor ITMN-191 (R7227) ... referred to as the INFORM-1 study, has been ...
... Response Data from Dose-Escalation Study Presented at , ... 2009 -SOUTH SAN FRANCISCO, Calif. and DENVER, April ... PARD ), a biopharmaceutical company focused on oncology, ... a Phase 1 dose-escalation study of picoplatin in ...
... Data on novel pro-apoptotic agent presented at the ... Cancer Research -- University of Pennsylvania ... lines, highlighting AT-101,s inhibition of Mcl-1, also presented ... announced today that the results of preclinical studies ...
Cached Biology Technology:INFORM-1 Clinical Trial Amended to Further Explore Promising Direct Antiviral Regimen in HCV Patients 2INFORM-1 Clinical Trial Amended to Further Explore Promising Direct Antiviral Regimen in HCV Patients 3INFORM-1 Clinical Trial Amended to Further Explore Promising Direct Antiviral Regimen in HCV Patients 4INFORM-1 Clinical Trial Amended to Further Explore Promising Direct Antiviral Regimen in HCV Patients 5Poniard Pharmaceuticals Presents Final Results of Phase 1 Study of Picoplatin in Patients with Metastatic Colorectal Cancer 2Poniard Pharmaceuticals Presents Final Results of Phase 1 Study of Picoplatin in Patients with Metastatic Colorectal Cancer 3Poniard Pharmaceuticals Presents Final Results of Phase 1 Study of Picoplatin in Patients with Metastatic Colorectal Cancer 4Poniard Pharmaceuticals Presents Final Results of Phase 1 Study of Picoplatin in Patients with Metastatic Colorectal Cancer 5Ascenta Therapeutics Announces Results of Preclinical Evaluation of AT-406 in Multiple Cancer Models 2Ascenta Therapeutics Announces Results of Preclinical Evaluation of AT-406 in Multiple Cancer Models 3
(Date:8/28/2014)... Mayo Clinic researcher and his collaborators have developed an ... the process of re-engineering cells for biomedical investigation. CellNet ... methods to aid stem cell engineering. Details of CellNet ... in two back-to-back papers in the journal Cell ... of uses for all types of cell-based investigations and ...
(Date:8/28/2014)... (Maximizing Access to Research Careers) Program has announced ... of America,s 27th Annual Mouse Molecular Genetics Conference ... Pacific Grove, California. These awards are meant ... and scientists from underrepresented groups into the mainstream ... the participation of young scientists at the Genetics ...
(Date:8/28/2014)... N.C. -- Scientists have identified the developmental on-off switch ... that produce more than two-thirds of the world,s naturally ... be to see whether it is possible to manipulate ... , The study, appearing August 28 in ... small molecule called cyclic-di-GMP and a larger protein called ...
Breaking Biology News(10 mins):New tool aids stem cell engineering for medical research 2Small molecule acts as on-off switch for nature's antibiotic factory 2Small molecule acts as on-off switch for nature's antibiotic factory 3
... State University researchers have uncovered a pattern of distrust ... hospitals and midwives who are transporting their home-birth clients ... State University assistant professor Melissa Cheyney and doctoral student ... between physicians and midwives that is reflective of discord ...
... Phase I SBIR grant of $1,296,403 from the ... "Differential Phase Contrast Imaging" using the unique x-ray ... The grant will allow Lyncean to continue ... and its applications to new methods of imaging ...
... built a new tissue scaffold that can stimulate bone ... other joints. The scaffold could offer a potential ... such as arthritis, says Lorna Gibson, the Matoula S. ... of the research team with Professor William Bonfield of ...
Cached Biology News:Study reveals conflict between doctors, midwives over homebirth 2Study reveals conflict between doctors, midwives over homebirth 3Lyncean Technologies Inc. receives $1.2 M from NCRR to develop new imaging technique 2MIT: New tissue scaffold regrows cartilage and bone 2
... Conjugate Stabilizer is an aqueous solution that ... non-toxic stabilizing chemicals in a MOPS buffer ... This product contains a combination of ... Proclin 300 (Rohm and Haas Company) as ...
Preparation Note: by a modification of the procedure of C.W. Hancher et al., Biotechnol. Bioeng. 11, 1055 (1969) Assay: ~ 20 A 260 /mg Solubility: water 10 mg/mL, clear, light-yellow Suitab tst...
Request Info...
This buffer is Specifically formulated to be used with Endogen's Poly-HRP Streptavidin...
Biology Products: